Clinical factors associated with patterns of endocrine therapy adherence in premenopausal breast cancer patients

Journal article

Abstract Introduction Patients with hormone receptor positive breast cancer are recommended at least five years of adjuvant endocrine therapy, but adherence to this treatment is often suboptimal. We investigated longitudinal trends in adjuvant endocrine therapy (AET) adherence among premenopausal breast cancer patients and identified clinical characteristics, including baseline comorbidities and non-cancer chronic medication use, associated with AET adherence. Methods We included stage I–III premenopausal breast cancer patients diagnosed during 2002–2011 and registered in the Danish Breast Cancer Group clinical database who initiated AET. We used group-based trajectory modeling to describe AET adherence patterns. We also linked patients to Danish population-based registries and fit multinomial logistic models to compute odds ratios (ORs) and 95% confidence intervals (95% CIs) associating clinical characteristics with AET adherence patterns. Results We identified three adherence patterns among 4,353 women—high adherers (57%), slow decliners (36%), and rapid decliners (6.9%). Women with stage I disease (vs. stage II; OR: 1.9, 95% CI 1.5, 2.5), without chemotherapy (vs. chemotherapy; OR: 4.3, 95% CI 3.0, 6.1), with prevalent comorbid disease (Charlson Comorbidity Index score ≥ 1 vs. 0; OR: 1.6, 95% CI 1.1, 2.3), and with a history of chronic non-cancer medication use (vs. none; OR: 1.3, 95% CI 1.0, 1.8) were more likely to be rapid decliners compared with high adherers. Conclusions Women with stage I cancer, no chemotherapy, higher comorbidity burden, and history of chronic non-cancer medication use were less likely to adhere to AET. Taking steps to promote adherence in these groups of women may reduce their risk of recurrence

Authors: Woolpert, KM; Schmidt, JA; Ahern, TP; Hjorth, CF; Farkas, DK

• Publication status: Published
• Peer review status: Peer reviewed
• Publisher: BioMed Central
• Journal: Breast Cancer Research
• Volume: 26
• Issue: 1
• Pages: 59-59
• Publication date: 2024-04-08
• DOI: 10.1186/s13058-024-01819-4
• EISSN: 1465-542X
• ISSN: 1465-5411
• Language: English
• Keywords: Odds ratio; Internal medicine; Population; Cancer; Hormonal therapy; Breast cancer; Oncology; Comorbidity; Gynecology; Medicine